Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 850 | 3,040 | 3,870 | 2,456 | 394 |
| Marketable Securities | 0 | 320 | 510 | 128 | N/A |
| Other current assets | 520 | 1,540 | 150 | 39 | 127 |
| TOTAL | $1,370 | $4,900 | $4,530 | $2,623 | $521 |
| Non-Current Assets | |||||
| PPE Net | 340 | 260 | 290 | 239 | 143 |
| Other Non-Current Assets | 320 | 260 | 210 | 0 | 0 |
| TOTAL | $660 | $520 | $500 | $239 | $143 |
| Total Assets | $2,050 | $5,450 | $5,040 | $2,863 | $690 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 850 | 1,230 | 770 | 0 | 0 |
| Accrued Expenses | 440 | 0 | 0 | N/A | N/A |
| Other current liabilities | 230 | 230 | 420 | N/A | N/A |
| TOTAL | $5,530 | $1,470 | $1,190 | $1,166 | $1,359 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,000 | 0 | 0 | N/A | 1,575 |
| Other Non-Current Liabilities | 600 | 4,390 | 2,180 | 0 | 0 |
| TOTAL | $5,600 | $4,390 | $3,180 | $N/A | $1,575 |
| Total Liabilities | $11,140 | $5,860 | $4,370 | $2,207 | $2,933 |
| Shareholders' Equity | |||||
| Common Shares | 290 | 280 | 270 | 271 | 127 |
| Retained earnings | -92,490 | -80,960 | -73,410 | N/A | N/A |
| Other shareholders' equity | 0 | 170 | 180 | 385 | -2,375 |
| TOTAL | $-9,080 | $-410 | $670 | $655 | $-2,249 |
| Total Liabilities And Equity | $2,060 | $5,450 | $5,040 | $2,863 | $685 |